Enter inventor name

Ting-Chao Chou

USPTO Granted Patents = 37 (Patent Applications = 4)

EPO Patents = 1 (Patent Applications = 1)

Average Co-Inventor Count = 4.6

ph-index = 9

Forward Citations = 280(Granted Patents)

Location History:

New York, NY (US) (1991 - 2012)
Paramus, NJ (US) (1999 - 2015)

Company Filing History:

28 out of 512

Sloan-kettering Institute for Cancer Research

National Health Research Institutes

patents

4. 1 out of 560

Memorial Sloan Kettering Cancer Center

patents

5. 1 out of 832,891

Other

patents

Years Active: 1991-2015

Loading Chart...

37 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9193687 - Phenyl N-mustard linked to DNA-affinic molecules or water-soluble aryl rings, method and their use as cancer therapeutic agents (2015-11-24),

2. 8859615 - Compounds, compositions and methods for reducing toxicity and treating or preventing diseases (2014-10-14),

3. 8772284 - Method of treating cancer using combination of a bifunctional alkylating agent and DNA repair inhibitors (2014-07-08),

4. 8703951 - Synthesis of 4H-benzo[D]pyrrolo[1,2-A]thiazoles and indolizino[6,7-b]indole derivatives and their use as antitumor therapeutic agents (2014-04-22),

5. 8513429 - Synthesis of epothilones, intermediates thereto and analogues thereof (2013-08-20),

6. 8481575 - Synthesis of epothilones, intermediates thereto, analogues and uses thereof (2013-07-09),

7. 8410130 - Synthesis of 8H-3A-aza-cyclopenta [A ]indenes and 5,10-dihydropyrrolo[1,2-B]isoquinolines derivatives and their use as antitumor therapeutic agents (2013-04-02),

8. 8222297 - Aniline or phenol mustards linked to DNA-affinic molecules or water-soluble aromatic rings and their use as cancer therapeutic agents (2012-07-17),

9. 8138170 - Immunosuppressive Ningalin compounds (2012-03-20),

10. 8110590 - Synthesis of epothilones, intermediates thereto and analogues thereof (2012-02-07),

11. 7875638 - Synthesis of epothilones, intermediates thereto, analogues and uses thereof (2011-01-25),

12. RE41990 - Synthesis of epothilones, intermediates thereto, analogues and uses thereof (2010-12-06),

13. 7759374 - Synthesis of epothilones, intermediates thereto and analogues thereof (2010-07-20),

14. 7750164 - Synthesis of epothilones, intermediates thereto, analogues and uses thereof (2010-07-06),

15. 7649006 - Synthesis of epothilones, intermediates thereto and analogues thereof (2010-01-19),

Title: Ting-Chao Chou: Pioneering Cancer Therapeutic Innovations

Introduction:

In the realm of cancer therapeutic research, few names stand out as brightly as Ting-Chao Chou. Hailing from Paramus, NJ, Ting-Chao Chou is a renowned inventor and researcher who has made significant contributions to the development of novel treatments for cancer. With an impressive portfolio of 37 patents and an illustrious career, his work continues to shape the field of oncology. This article delves into Ting-Chao Chou's latest patents, career highlights, collaborations, and his invaluable contributions towards advancing cancer therapies.

Latest Patents:

Ting-Chao Chou's most recent patents demonstrate his commitment to developing innovative and effective cancer therapeutic agents. One notable invention is the "Phenyl N-mustard linked to DNA-affinic molecules or water-soluble aryl rings, method and their use as cancer therapeutic agents." This patented technology focuses on new DNA-directed alkylating agents, enhancing stability, and improving the efficacy of N-mustard agents in tumor treatment.

Additionally, Chou's inventions include compounds, compositions, and methods for reducing toxicity and treating or preventing diseases. This patent covers formulations comprising specific compounds effective in reducing the toxicity of cytotoxic agents, treating cancer or neuropathic disorders, inducing protective enzymes, enhancing immune response, treating inflammation, and improving overall well-being.

Career Highlights:

Ting-Chao Chou's illustrious career encompasses invaluable contributions to cancer research. He notably worked at prestigious institutions such as Sloan-Kettering Institute for Cancer Research and Academia Sinica. During his tenure at these esteemed organizations, Chou pioneered groundbreaking research and played an integral role in the development of cancer therapeutic innovations.

Collaborations:

Throughout his career, Ting-Chao Chou has collaborated with distinguished scientists and researchers. Notably, he has worked closely with Samuel J Danishefsky, an eminent chemist, and Peter Bertinato, another influential figure in the field of oncology. These collaborations have facilitated the exchange of ideas, shared expertise, and contributed to significant advancements in cancer therapeutics.

Conclusion:

Ting-Chao Chou stands as a trailblazer in the field of cancer therapeutic research, with an impressive list of patents and a formidable career. Through his innovative contributions, Chou has paved the way for the development of novel treatments that offer enhanced efficacy and reduced toxicity. His collaborations with esteemed scientists have further enriched the field of oncology, fostering advancements that benefit patients worldwide.

It is through the dedication and pioneering spirit of individuals like Ting-Chao Chou that we continue to witness remarkable progress in the fight against cancer. His patents and career highlights serve as an inspiration to aspiring inventors and researchers, reminding us of the profound impact that innovation can have on improving patient outcomes and ultimately, saving lives.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com